Metraipolis › archive › dc_f710a2649eab

Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41009716
DOI
10.3390/ijms26189154
License (as archived)
solo-consultazione
Archived
2026-11-09T21:05:49.254Z
SHA-256 of the archived text
6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6
Stable URL of this page
https://metraipolis.com/documento/dc_f710a2649eab

How to cite

Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716 — Europe PMC (en), https://europepmc.org/article/MED/41009716 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f710a2649eab (Metraipolis archive dc_f710a2649eab, sha256 6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6)
BibTeX
@misc{dcf710a2649eab,
  title = {Blood-Based Inflammatory Markers Are Associated with Treatment Outcomes in Head and Neck Squamous Cell Carcinoma Receiving Anti-PD-1 Therapy: CRP as a… — Europe PMC PMID:41009716},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41009716},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f710a2649eab; sha256 6eef8d9ac808e2a6c5b67576677b145512eceecf746f06be7cf7feb79059e1d6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41009716. Agents can read the archived copy with the MCP tool read_document.